The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2R,4R)-1-((R)-2-((S)-2-acetamido-3-(4-hydroxyphenyl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide ID: ALA375559
Max Phase: Preclinical
Molecular Formula: C39H45N7O6
Molecular Weight: 707.83
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N1C[C@H](OCc2ccc3ccccc3c2)C[C@@H]1C(=O)NCCN=C(N)N
Standard InChI: InChI=1S/C39H45N7O6/c1-25(47)44-33(20-27-12-15-31(48)16-13-27)36(49)45-34(21-26-7-3-2-4-8-26)38(51)46-23-32(22-35(46)37(50)42-17-18-43-39(40)41)52-24-28-11-14-29-9-5-6-10-30(29)19-28/h2-16,19,32-35,48H,17-18,20-24H2,1H3,(H,42,50)(H,44,47)(H,45,49)(H4,40,41,43)/t32-,33+,34-,35-/m1/s1
Standard InChI Key: VZGJDZXPTNTGFA-AOJHZZQJSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 707.83Molecular Weight (Monoisotopic): 707.3431AlogP: 1.90#Rotatable Bonds: 15Polar Surface Area: 201.47Molecular Species: BASEHBA: 7HBD: 6#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 8#RO5 Violations (Lipinski): 3CX Acidic pKa: 9.50CX Basic pKa: 11.28CX LogP: 1.41CX LogD: -0.24Aromatic Rings: 4Heavy Atoms: 52QED Weighted: 0.06Np Likeness Score: 0.07
References 1. Tian X, Field TB, Switzer AG, Mazur AW, Ebetino FH, Wos JA, Berberich SM, Jayasinghe LR, Obringer CM, Dowty ME, Pinney BB, Farmer JA, Crossdoersen D, Sheldon RJ.. (2006) Design, synthesis, and evaluation of proline and pyrrolidine based melanocortin receptor agonists. A conformationally restricted dipeptide mimic approach., 49 (15): [PMID:16854081 ] [10.1021/jm060384p ]